Deutsche Bank rep fined $5,000 for role in outside medical marijuana business

Finra also suspends Mina Mishrikey for three months

Apr 13, 2018 @ 2:26 pm

By InvestmentNews

Finra has fined Mina Mishrikey $5,000 and suspended him for three months because he continued to participate in a medical marijuana business after his firm told him not to.

The Financial Industry Regulatory Authority Inc. said that in September 2016, Mr. Mishrikey sought approval from Deutsche Bank, his employer, to participate in a company that intended to submit a license to the Commonwealth of Pennsylvania to produce and sell medical marijuana pursuant to the state's medical marijuana law.

Although the firm denied his request, Mr. Mishrikey continued to work as a director of the company through July 2017, Finra said in its letter of acceptance, waiver and consent. He also failed to notify Deutsche Bank that he had continued to participate in the prohibited outside business activity and initially denied that he was doing so when his firm confronted him.

(More: Rogue brokers still pose a danger to investors)

0
Comments

What do you think?

View comments

Recommended for you

Featured video

Events

3 Questions to ask yourself when making your succession plan

Michael Futterman from Janus Henderson Investors has sage advice for advisers as they approach retirement.

Latest news & opinion

CFA Institute adding crypto, blockchain to curriculum

Subjects will be added to its Level I and II coursework for the first time next year.

Trump tax plan making dividend ETFs hot

Funds that are seeing inflows largely steer clear of sectors like utilities.

Wells Fargo Advisors continues to see a decline in brokers

Company also set aside $114 million over fees for rich clients.

Morningstar to replace funds in its managed portfolios with nine of its own

New sub-advised funds, offered exclusively through financial advisers, are intended to lower costs and provide 'greater flexibility.'

Average client assets top $2 million for first time

Charles Schwab's latest RIA Benchmarking Study reports organic growth is driving increased AUM and revenues.

X

Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print